BioStem Announces Publication of a Standardized Method to Evaluate Growth Factor Elution from Placental Tissue Allografts
13. September 2022 07:30 ET
|
BioStem Technologies, Inc.
Standardized methodology demonstrates high presence of placental membrane growth factors in BioStem’s Vendaje® and Vendaje AC® tissue allografts POMPANO BEACH, FLORIDA., Sept. 13, 2022 (GLOBE...
BioStem Technologies, Inc. Receives TRIP (TRG Rapid Inquiry Program) Response for VENDAJE™
25. März 2021 09:00 ET
|
BioStem Technologies, Inc.
Pompano Beach, Fl., March 25, 2021 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) ("BioStem" or the "Company"), a pre-clinical-stage biotechnology company focused on harnessing...
BioStem Technologies Engages D. Brooks & Associates for 2020 and 2019 Audit
15. März 2021 09:00 ET
|
BioStem Technologies, Inc.
Pompano Beach, Fl., March 15, 2021 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) ("BioStem" or the "Company"), a leading pre-clinical-stage biotechnology company focused on...
BioStem Technologies, in Partnership with Veterans Medical Distributors Inc., Announces Five-Year Federal Supply Schedule Contract with the Department of Veterans Affairs
01. September 2020 17:00 ET
|
BioStem Technologies, Inc.
Pompano Beach, Fl., Sept. 01, 2020 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) ("BioStem" or the "Company"), a leading life sciences company specializing in perinatal tissue...
BioStem Life Sciences Signs Manufacturing Agreement for Amniotic Membrane Allograft Platform
11. August 2020 09:00 ET
|
BioStem Technologies, Inc.
Pompano Beach, FL, Aug. 11, 2020 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) a leading life sciences company specializing in the development and sale of perinatal tissue-based...
BioStem Technologies, Inc. Announces Tissue Bank Certification in California and Maryland
26. Juni 2020 09:00 ET
|
BioStem Technologies, Inc.
Pompano Beach, FL, June 26, 2020 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) ("BioStem" or the "Company") a leading life sciences company specializing in perinatal tissue-based...
BioStem Technologies Announces Corporate Update on Company Direction
29. April 2020 12:35 ET
|
BioStem Technologies, Inc.
Pompano Beach, FL, April 29, 2020 (GLOBE NEWSWIRE) -- BioStem Technologies, Inc. (OTC PINK: BSEM) ("BioStem" or the "Company") a leading life sciences company specializing in perinatal tissue-based...
BioStem Life Sciences Announces Expansion; Contract Manufacturing Capabilities, and Research and Development Laboratory
13. März 2020 09:30 ET
|
BioStem Technologies, Inc.
Pompano Beach, FL, March 13, 2020 (GLOBE NEWSWIRE) -- BioStem Life Sciences, a wholly owned subsidiary of BioStem Technologies, Inc. (OTC PINK: BSEM) ("BioStem" or the "Company") a leading life...